| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S1007-Breast,Adj,N1,Endocrine+/-Chemo | 1 | N | 1 Recurrence Score testing | 9400 | 9383 | 0 | 0 | 0 | 0 | 0 | 02/28/2011 | 473 | 196 |
| 9383 | 0 | 0 | 0 | 0 | 0 | |||||||||
| 2 | N | 2 Chemo and Endocrine Therapy | 2547 | 0 | 0 | 0 | 0 | 0 | 02/28/2011 | |||||
| 3 Endocrine Therapy Alone | 2536 | 0 | 0 | 0 | 0 | 0 | ||||||||
| 5083 | 0 | 0 | 0 | 0 | 0 | |||||||||
| 3 | Y | 4 Specimen Submission for CBALR TM Substudy | 173 | 15 | 4 | 3 | 0 | 0 | 02/28/2011 | |||||
| 173 | 15 | 4 | 3 | 0 | 0 | |||||||||
| S1706-Breast, Inflammatory, RT +/- Olaparib | 1 | Y | 1 Olaparib + RT | 300 | 64 | 16 | 10 | 5 | 0 | 0 | 01/18/2019 | 228 | 98 | |
| 2 RT | 67 | 11 | 9 | 2 | 0 | 0 | ||||||||
| 131 | 27 | 19 | 7 | 0 | 0 | |||||||||
| S2007-Breast, Brain Mets, Sacituzumab Govitecan | 1 | Y | 1 Sacituzumab Govitecan | 44 | 19 | 8 | 2 | 0 | 0 | 0 | 06/08/2021 | 219 | 78 | |
| 19 | 8 | 2 | 0 | 0 | 0 | |||||||||
| Yes | A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib | 1 | E | Total Registrations | 25 | 16 | 9 | 5 | 1 | 0 | 03/11/2021 | 407 | 197 | |
| 25 | 16 | 9 | 5 | 1 | 0 | |||||||||
| EA1181-BRST, HER2-pCR, Preop THP and Postop HP | 1 | E | Total Registrations | 113 | 40 | 16 | 10 | 5 | 0 | 03/17/2020 | 335 | 148 | ||
| 113 | 40 | 16 | 10 | 5 | 0 | |||||||||
| EA1183-Brst, Met, FDG PET Assess Response, FEATURE | 1 | E | Total Registrations | 13 | 3 | 0 | 0 | 0 | 0 | 01/06/2021 | 133 | 59 | ||
| 13 | 3 | 0 | 0 | 0 | 0 | |||||||||
| MA39-BREAST, Node-Pos, Reg RT vs No Reg RT | 1 | E | Total Registrations | 16 | 8 | 6 | 3 | 2 | 1 | 10/18/2019 | 362 | 136 | ||
| 16 | 8 | 6 | 3 | 2 | 1 | |||||||||
| 2 | E | Total Registrations | 16 | 7 | 5 | 3 | 3 | 1 | 10/18/2019 | |||||
| 16 | 7 | 5 | 3 | 3 | 1 | |||||||||
| NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA | 1 | T | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/22/2017 | 175 | 63 | ||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv | 1 | T | Total Registrations | 7 | 0 | 0 | 0 | 0 | 0 | 06/22/2018 | 191 | 62 | ||
| 7 | 0 | 0 | 0 | 0 | 0 | |||||||||
| No | B42- | 1 | E | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 08/10/2009 | 14 | 9 | |
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| NRGBR007-Breast, Stg I, De-Escalation of Breast RT | 1 | E | Total Registrations | 3 | 3 | 1 | 0 | 0 | 0 | 06/01/2022 | 320 | 150 | ||
| 3 | 3 | 1 | 0 | 0 | 0 | |||||||||
| 2 | E | Total Registrations | 3 | 3 | 1 | 0 | 0 | 0 | 06/01/2022 | |||||
| 3 | 3 | 1 | 0 | 0 | 0 | |||||||||